is still incomplete. Here we used pharmacological conditioning with carbamazepine, dextrometorphan, lorazepam, and placebo to elucidate the type of plasticity underlying this facilitation, and to probe if mechanisms reminiscent of long-term potentiation are involved. Over the primary motor cortex of 10 healthy subjects, we applied biphasic rTMS pulses of effective posterior current direction in the brain. We used six blocks of 200 pulses at 5-Hz frequency and 90% active motor threshold intensity and controlled for corticospinal excitability changes using motor-evoked potential (MEP) amplitudes and latencies elicited by suprathreshold pulses before, in between, and after rTMS. Target muscle was the dominant abductor digiti minimi muscle; we coregistered the dominant extensor carpi radialis muscle. We found a lasting facilitation induced by this type of rTMS. The GABAergic medication lorazepam and to a lesser extent the ion channel blocker carbamazepine reduced the MEP facilitation after biphasic effective posteriorly oriented rTMS, whereas the N-methyl-D-aspartate receptor-antagonist dextrometorphan had no effect. Our main conclusion is that the mechanism of the facilitation induced by biphasic effective posterior rTMS is more likely posttetanic potentiation than long-term potentiation. Additional findings were prolonged MEP latency under carbamazepine, consistent with sodium channel blockade, and larger MEP amplitudes from extensor carpi radialis under lorazepam, suggesting GABAergic involvement in the center-surround balance of excitability.
REPETITIVE TRANSCRANIAL MAGNETIC stimulation (rTMS) modulates corticospinal excitability and is widely used in many disciplines, including clinical trials (Janicak et al. 2010; O'Reardon et al. 2007 ) and FDA approval in depression (Melkerson 2008) . Though the motor cortex has been abundantly studied using rTMS (Pell et al. 2011; Ridding and Ziemann 2010) , our knowledge about the mechanisms of action of rTMS applied in humans is still limited. In particular, studies elucidating mechanisms of rTMS by pharmacological conditioning are scarce.
It is long known that rTMS can induce a lasting facilitation of the corticospinal tract, and that the use of stimulus intensities below the motor threshold ensures a mostly cortical site of action (Bestmann et al. 2004; Huang et al. 2005) , particularly when the intensity is below the active motor threshold (AMT), i.e., too weak to activate the corticospinal tract even during voluntary activation of the target muscle (Quartarone et al. 2005; Sommer et al. 2012) .
We have further characterized this facilitation outlasting subthreshold rTMS pulses by showing that they are best induced by using biphasic pulses inducing effective posteriorly directed currents in the motor cortex (Rothkegel et al. 2010; Sommer et al. 2012 ). However, this specific facilitation elicited even with such low intensity was of rather short duration, only some 15 min, shorter than has been reported with stronger stimuli (Pascual-Leone et al. 1994) or theta burst stimulation (Huang et al. 2005 ). We were skeptical as to whether mechanisms reminiscent of long-term potentiation (LTP) would be involved in that type of plasticity.
We therefore tried to further characterize the nature of this facilitation by testing its sensitivity to pharmacological conditioning. In particular, we evaluated N-methyl-D-aspartate (NMDA) antagonism, known to reduce the induction of LTP (Netzer et al. 1993) , carbamazepine (CBZ), known to block voltage-dependent sodium channels (White 1997) , and lorazepam (LOR), known to block many neuroplastic processes (Treiman 2001; White 1997) .
METHODS
Participants and drug conditions. The study protocol was approved by the University of Goettingen ethics committee, and written, informed consent was obtained from all participants. We conducted a five-armed double-blind placebo (PLC)-controlled pharmacological study in 10 healthy, right-handed subjects (six women, mean age 23.9, range 19 -35 yr; mean Oldfield handedness score of 91.5, standard deviation 21.5 points; no regular intake of central nervous systemactive medication). Subjects were recruited from the University campus and paid for participation. They were free to withdraw participation at any point. They were instructed on the blinded testing of different, well-established centrally active drugs and PLC, and they were informed about common side effects and asked to report eventual side effects. The sample size was based on the presence or absence of an rTMS effect with regard to the first five bins after the two types of biphasic rTMS shown in Fig. 1 of Sommer et al. (2012) , yielding an 2 of 0.19 and an effect size of f ϭ 0.48, with a correlation between repeated measures of 0.6. A power analysis (Gpower 3.1.5, University of Kiel, Germany) for repeated-measures ANOVA based on four measurements in one group indicated that with nine subjects our study would have a power of 95%. The same power can be achieved in a pre-post comparison at the usual two-sided significance level of 5%, with a same sample size of nine subjects, as long as the standardized effect size is at least 1.4, which is supported by findings of Quararone and colleagues (2005) on 5-Hz rTMS in healthy subjects. In our study, the participants were studied in the morning 12 h after an evening oral dose of medication and 2 h after a morning oral dose of medication. The CBZ condition consisted of 300 mg of CBZ in the evening and in the morning, the LOR condition of 2 mg LOR in the morning preceded by PLC in the evening, the dextrometorphan (DMO) condition of 150 mg DMO in the morning preceded by PLC in the evening, and the PLC condition of PLC both in the evening and in the morning. There was at least 1-wk delay in between measurements to account for possible carry-over effects, and the order of experiments was randomized. Serum levels (Geradin et al. 1976; Greenblatt et al. 1979; Silvasti et al. 1987 ) and central nervous effects of these drugs at these dosages can be expected to peak about 2 h after oral intake (Ziemann et al. 1996a (Ziemann et al. , 1996b (Ziemann et al. , 1998a . CBZ is better tolerated if taken in two consecutive dosages (Nitsche et al. 2003) .
To elucidate the mechanisms of the facilitation observed after 5-Hz rTMS, we used biphasic pulses with effective current direction in the brain from anterior to posterior (biphasic p-a/A-P, named "biphasic-P") in four conditions (LOR, CBZ, DMO, PLC). We highlight the second component of the induced current (Sommer et al. 2012 ) covering the second and third quarter cycles (Kammer et al. 2001; Sommer et al. 2006) , which is more important than the initial quarter cycle (Maccabee et al. 1998; Salvador et al. 2011) , primarily because of its longer duration (Maccabee et al. 1998) . For the sake of clarity, the current directions indicated in this paper always refer to the induced current flow in the brain.
CBZ blocks voltage-dependent sodium channels and high-frequency spiking (White 1997) . In the human corticospinal tract, it raises the motor threshold, but does not have a pronounced effect on intracortical inhibition or facilitation (Ziemann et al. 1996b ). CBZ blocks rTMS-induced motor-evoked potential (MEP) facilitation (Inghilleri et al. 2004) . LOR is a benzodiazepine reinforcing GABA A action on chloride channels by modulating the channel opening frequency (Treiman 2001; White 1997) . It enhances short latency intracortical inhibition and reduces intracortical facilitation, but leaves the motor threshold mostly unchanged (Ziemann et al. 1996a ). It reduces plasticity in experimental (Fitzgerald et al. 2005; Werhahn et al. 2002; Ziemann et al. 2001 ) and clinical settings (Conca et al. 2000; Teo et al. 2009; Wan et al. 2004 ), e.g., after stroke, thereby worsening the functional recovery of the patients (Lazar et al. 2003) . DMO is an NMDA receptor antagonist, and at high dose levels it also has channel-blocking properties (Netzer et al. 1993) . It reduces intracortical facilitation and has no major effect on the motor threshold (Ziemann et al. 1998a) . DMO blocked plasticity in a variety of experimental settings (Fitzgerald et al. 2005; Stefan et al. 2002; Wolters et al. 2003) .
All drugs were prepared by the pharmacy of the University of Goettingen, packed in identical blue capsules and delivered in separate, clearly designated jars. Medication for each experiment of each subject was packed in a blister containing the evening and the morning dose in separate spaces by a physician not involved in data recording and analysis (N. Lang), and each blister was marked with the subject number and experiment number. The subjects and the investigators involved in data recording (M. Rummel and M. Sommer) were blinded to the drug status during data acquisition and analysis. Only after off-line measurement and normalization and averaging of motor threshold, MEP amplitudes, and latencies was blinding broken to allow calculating statistics. We did not control for serum levels, which is a limitation of this study, but asked each subject at each experiment for a detailed report of side effects, which were meticulously noted.
To further confine the specificity of the observed facilitation (Sommer et al. 2012 ) in a distinct group of subjects, we used half-sine initially posteriorly oriented pulses [half-sine a-p (Sommer et al. 2006 )] in one additional PLC condition. We intended to use monophasic pulses for comparison, these turned out to be of half-sine configuration because of a technical defect in the new MagPro stimulator that we specified elsewhere (Sommer et al. 2006; see editorial Valls-Solé and Hallett 2006) .
Transcranial magnetic stimulation procedure. During the experimental sessions, participants were sitting comfortably in a reclining chair with the arms and neck supported. EMG recordings of the abductor digiti minimi muscle (ADM) and the extensor carpi radialis (ECR) muscle on the side of the dominant hand were recorded by separate pairs of silver-silver chloride electrodes in a belly-tendon montage. The ADM served as target muscle; the more proximal muscle was studied to assess a possible dissociation between excitability changes in the cortical representation of proximal and distal muscles (Tings et al. 2005) . For recording we used the "Signal" software at a sampling rate of 10 kHz, and filtered at 1.6 Hz and 1 kHz (CED 1401, Cambridge Electronic Design, Cambridge, UK). To control for muscle relaxation, audiovisual feedback was provided, and 50 ms of pre-TMS EMG were recorded during each trial. The coil was hand held over the dominant hemisphere by the investigators (M. Rummel or M. Sommer). The coil position was frequently controlled and corrected, if necessary. Hence, participants were under constant supervision, which allowed ensuring a stable level of attention throughout the experiment.
Biphasic and half-sine TMS pulses were generated by a MagPro X100 MagOption (Medtronic, Minneapolis, MN) stimulator connected to a slightly bent figure-of-eight coil (MC B70, Dantec S.A., Skovlunde, Denmark). In each session, the suprathreshold stimuli delivered before and after rTMS and in between rTMS blocks were of the same type and orientation as the rTMS pulses. We determined the optimal dominant hand motor representation of the ADM by applying single TMS pulses with the coil held perpendicular to the presumed localization of the central sulcus and with the handle pointing backwards at about 45°laterally. The position yielding the highest MEP amplitudes was marked with a pen. The resting motor threshold (RMT) with regard to the ADM was determined by delivering single TMS pulses over the marked position and by reducing the stimulus intensity in steps of ϳ1% stimulator output. RMT was defined as the lowest intensity at which at least 5 out of 10 consecutive MEPs were Ͼ50 V in amplitude with the subject at rest. Similarly, we determined the AMT as the minimal intensity evoking MEP amplitudes in the ADM of at least 250 V in 5 of 10 consecutive trials during slight voluntary contraction of the target muscle (Rossi et al. 2009; Rothwell et al. 1999) .
To determine a baseline of corticospinal excitability, rTMS was preceded by four consecutive bins of 30 single pulses at 0.25 Hz at an intensity adjusted to yield baseline MEP amplitudes in the ADM of about 1 mV. Immediately following this baseline, six blocks of 200 pulses each were delivered at 5-Hz frequency (Sommer et al. 2012 ). The intensity of 5-Hz stimulation was 90% AMT of the ADM. During each interval of 2 min in between the rTMS blocks, 15 pulses of baseline intensity were applied at 0.25-Hz frequency. After the end of rTMS, this assessment of corticospinal excitability was prolonged for 12 consecutive bins of 30 pulses at 0.25 Hz and of baseline intensity to detect possible lasting effects. Figure 1 illustrates this experimental design. We used subthreshold rTMS pulses in these experiments because 1) earlier trials with suprathreshold pulses at 5 Hz were limited in duration of stimulation by safety concerns (Tings et al. 2005) ; and 2) we intended to ensure a mostly cortical site of effect (Di Lazzaro et al. 2004 ). All these procedures were done anew for each session, to account for eventual drug effects on threshold eventually requiring adjustments of stimulus intensity.
Data analysis. For analysis, we normalized the individual mean amplitudes of each bin to the corresponding baseline. In a first step, we compared the two PLC conditions using a repeated-measures ANOVA across all time bins with muscle and time as well as well as type of rTMS as within-subjects factors. In a second step, we compared the four conditions for biphasic effective posteriorly oriented pulses (CBZ, LOR, DMO, PLC) using a repeated-measures ANOVA with muscle and time as well as drug as within-subject factors. Here, effects during and after rTMS were analyzed separately, focusing on the last two bins during rTMS and the first two bins after rTMS where a maximum rTMS effect could be expected (Sommer et al. 2012) . Based on significant main effects, we compared each bin of MEPs during rTMS to baseline with exploratory two-tailed, paired t-tests.
Drug effects on the baseline MEP amplitudes were assessed on individual mean baseline MEP amplitude using a repeated-measures ANOVA with drug and muscle as between-subjects factors. Based on significant main effects or interactions, exploratory post hoc t-tests compared drug effects, separate for each muscle.
Drug effects on the baseline RMT and AMT as well as the mean MEP amplitude were assessed using a repeated-measures ANOVA with drug and presence of voluntary muscle contraction (AMT, RMT) as between-subjects factors. Based on significant main effects, post hoc, Bonferroni-corrected t-tests compared drug effects. We went on to calculate similar ANOVAs separately for AMT and RMT. We measured the MEP onset latency for the ADM from the 21st to the 30th MEP of the second baseline bin, chosen to ensure baseline stability (Tegenthoff et al. 2005) and to minimize any putative influence of pre-TMS activity (Pasley et al. 2009) , and the first bin after rTMS, and analyzed drug and rTMS effects on the MEP latency using a repeated-measures ANOVA with drug and time as within-subjects factors. With regard to half-sine pulses, AMT, RMT, and latency are reported in Fig. 2 , but not included in the analysis. For all significant main effects or interactions of all analyses, we indicated the effect size 2 as calculated from the SPSS 20.0 repeated-measures general linear model (International Business Machines, Armonk, NY).
RESULTS
Adverse events. Side effects reported by the subjects included the following: LOR: fatigue (8 subjects), ataxia (5), dizziness (2), mnestic difficulties (2), nausea (2); CBZ: dizziness (7), fatigue (5), nausea (2), ataxia (1); DMO: ataxia (7), dizziness (7), nausea (7), euphoria (4), fatigue (1). These side effects reached their maximum within 1-4 h after intake and were fully reversible until the morning after the experiment. None of the subjects opted to drop out of the study.
Motor threshold, MEP amplitude, and MEP latency. The motor threshold was higher after CBZ intake than at any other drug condition [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 3.61, P ϭ 0.026, 2 ϭ 0.02; effect of voluntary muscle contraction, F(1,9) ϭ 40.30, P Ͻ 0.0001, 2 ϭ 0.21; interaction of drug by innervation, F(3,27) ϭ 4.52, P ϭ 0.011, 2 ϭ 0.005; Fig. 2 ]. Post hoc t-tests showed that the CBZ condition yielded higher thresholds than the DMO condition. The difference between CBZ and PLC slightly failed the Bonferroni-correction threshold of the post hoc t-test. The relative increase between AMT and RMT was largest for CBZ and smallest for DMO, but post hoc t-tests did not yield significance.
Separate ANOVAs for RMT and AMT confirmed a drug effect on RMT [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 6.03, P ϭ 0.04, 2 ϭ 0.04], but not on AMT [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 1.09, P ϭ 0.37].
Similarly, the stimulus intensity necessary to induce MEP amplitudes of about 1 mV was highest in the CBZ condition [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 4.28, P ϭ 0.014, 2 ϭ 0.04; Fig. 2 ]. Post hoc t-tests confirmed a significant difference between CBZ and PLC, as well as between CBZ and DMO. The MEP latency from ADM was longer under CBZ than under any other condition; it was not altered by rTMS [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 5.12, P ϭ 0.006, 2 ϭ 0.17; effect of time, F(1,9) ϭ 0.01, P ϭ 0.92; no significant interaction; Fig. 2 ]. Post hoc t-tests confirmed a significant difference between CBZ and LOR, as well as between CBZ and PLC.
The baseline MEP amplitude of ADM and ECR muscles are shown in Fig. 3 ; they were not significantly different between drug conditions in either muscle [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 1.04, P ϭ 0.39; effect of muscle, F(1,9) ϭ 0.003, P ϭ 0.99; interaction of muscle by drug, F(3,27) ϭ 3.36, P ϭ 0.033, 2 ϭ 0.04, no other significant interactions; Fig. 3 ]. Post hoc t-tests separate for each muscle yielded a significant difference between LOR and PLC for the ECR muscle only.
Comparison of PLC conditions. The analysis of the two PLC arms confirmed a facilitation with biphasic effective posteriorly oriented pulses, but not with half-sine initially posteriorly oriented pulses [effect of rTMS type, F(1,9) ϭ 6.1, P ϭ 0.036, 2 ϭ 0.07; effect of time, F(20,180) ϭ 2.1, P ϭ 0.0051, 2 ϭ 0.05; no effect of muscle; interaction of type by time, F(20,180) ϭ 2.44, P ϭ 0.001, 2 ϭ 0.05; see Fig. 4 ]. The absence of facilitation with half-sine pulses under PLC corroborates the orientation specificity of this facilitation discussed elsewhere (Sommer et al. 2012) , i.e., that this facilitation is specifically induced with biphasic pulses that have a posterior current flow in the brain with regard to their decisive second and third quarter cycle component (Maccabee et al. 1998) . Drug effects during rTMS. For the last two bins during rTMS, no drug influence was found [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 0.51, P ϭ 0.67; effect of muscle, F(1,9) ϭ 0.85, P ϭ 0.38, no effect of time, no significant interaction; Fig. 5] .
Drug effects after rTMS. LOR, and to a lesser extent CBZ, diminished the MEP facilitation after biphasic effective posteriorly oriented rTMS, whereas DMO had no major effect [repeated-measures ANOVA, effect of drug, F(3,27) ϭ 3.7, P ϭ 0.023, 2 ϭ 0.12; effect of muscle, F(1,9) ϭ 6.4, P ϭ 0.033, 2 ϭ 0.04, no effect of bin, no significant interaction; Fig. 5 ]. Post hoc t-tests yielded a significant difference between LOR and PLC, as well as between LOR and DMO (P Ͻ 0.02); the difference between CBZ and PLC slightly missed significance (P ϭ 0.065).
DISCUSSION
The facilitation observed for about 20 min after subthreshold rTMS is blocked by LOR and reduced by CBZ, but not by DMO. There was no prolongation of the after-effects induced by any of the drugs tested.
CBZ also reduced the MEP facilitation induced by suprathreshold 5-Hz rTMS (Inghilleri et al. 2004) , which was attributed to its sodium-channel blocking properties. The blockage of the facilitation by CBZ is reminiscent of its effects on the facilitation of MEP amplitudes evoked by anodal transcranial direct current stimulation (tDCS) both during and after stimulation (Liebetanz et al. 2002; Nitsche et al. 2003) . Again, this was explained by a blockage of voltage-dependent sodium channels (Nitsche et al. 2003) . Similarly, models of epilepsy have shown a decreased spike frequency after kindling following treatment with CBZ (White 1997) . Prolongation of evoked potential latency by CBZ has been shown for laser evoked potentials (Cruccu et al. 2001 ), but not for MEPs, to the best of our knowledge. The prolonged MEP latency under CBZ influence may be related to a longer delay until a sufficient proportion of motoneurons have reached their firing threshold (Rothwell et al. 1991) .
LOR clearly suppressed the short-lasting MEP facilitation. When investigated in the context of tDCS, LOR delayed the facilitation induced by anodal tDCS (Nitsche et al. 2004) . It reduced the facilitation of MEP amplitudes in conjunction with a reduction of intracortical inhibition induced by the combined intervention of ischemic nerve block (INB) at the level of the elbow and slow rTMS over the corresponding motor cortex (Ziemann et al. 1998b ). This and the appearance of latent cortico-cortical connections after GABA blockade in rats (Jacobs and Donoghue 1991) suggest that the inhibitory activity of GABA blocks many neuroplastic processes.
DMO, in our study, did not modify the facilitation of MEP amplitudes. However, DMO abolished the lasting facilitation after longer tDCS stimulation (Liebetanz et al. 2002; Nitsche et al. 2003) , but not after shorter stimulation (Nitsche et al. 2003) . For INB, it did not block the MEP facilitation, but the decrease of intracortical inhibition induced by INB in combination with slow-frequency rTMS (Ziemann et al. 1998b) .
Taken together, the pharmacological profile observed in our study does not favor LTP as the underlying mechanism, since it depends on glutamate-mediated synaptic enhancement and can be blocked in vitro by glutamate receptor antagonists (Kirkwood et al. 1993) , whereas DMO did not block the facilitation observed here. An insufficient DMO dosage is unlikely, since it was chosen according to the published literature (Liebetanz et al. 2002; Nitsche et al. 2003; Ziemann et al. 1998a ) and elicited clinically relevant side effects. Short-term potentiation (STP) probably has different underlying mechanisms (Citri and Malenka 2008) and may lower the threshold for LTP induction. However, one report claims that it is NMDA dependent as well (Schulz and Fitzgibbons 1997) . Shorter lasting modulations include posttetanic potentiation (PTP), which is NMDA-receptor independent (Schulz and Fitzgibbons 1997; Swandulla et al. 1991) and is diminished by LOR (Brown et al. 1983 ) and by CBZ (Talwar 1990 ). Hence, STP and particularly PTP are a more likely candidate mechanism for the facilitation observed here. PTP has shown to depend essentially on presynaptic mechanisms such as an increased frequency of spontaneous neurotransmitter vesicle release (Habets and Borst 2005) and increase of calcium influx per action potential (Habets and Borst 2006) . To our knowledge, a possible association of rTMS and PTP has not been systematically studied before and has only been alluded to in the context of postexercise facilitation (Samii et al. 1996 (Samii et al. , 1998 . Inghilleri and coworkers (2004) implicated postsynaptic NMDA-receptor dependent mechanisms in their findings on a blockade of rTMS-related MEP facilitation in humans by CBZ, but our results regarding DMO do not support that assumption.
When comparing the two PLC arms, the rTMS-induced facilitation was specific for biphasic p-a/A-P pulses and not seen with half-sine a-p pulses. This further stresses the pivotal interaction of waveform with motor cortex anisotropy elaborated elsewhere (Sommer et al. 2012) .
Unexpectedly, the baseline MEP amplitude yielded an interaction muscle by drug. It was carried by MEP amplitudes from the nontarget muscle ECR, which were larger under LOR influence than under PLC. It is tempting to relate this to differences in center-surround interaction, for which the precise role of GABA is still controversial (overview in Beck and Hallett 2010) . Modulation of GABAergic transmission is known to unravel latent intracortical connections between motor representations, e.g., under influence of bicuculline in rats (Jacobs and Donoghue 1991) . Bicuculline, however, is regarded as an antagonist of the GABA A receptors (Jacobs and Donoghue 1991, see discussion in Ziemann et al. 1998b ), whereas LOR is regarded as an agonist of the GABA A receptors (White 1997) . This apparent contradiction might be reconciled by assuming a double inhibitory mechanism ending up in effective disinhibition. The specific and well-defined rTMS pulses we used have the mainly effective current-flow in the posterior direction, likely suited for stimulating pyramidal tract neurons along their axis from layer VI to I, thereby depolarizing the dendritic tree (Fox et al. 2004; Sommer et al. 2012) . Speculatively, this could have contributed to enhancing LORrelated inhibition in this paradigm.
Limitations of this study comprise the small sample size and the use of drug dosages not adapted to serum levels.
In conclusion, we have identified that the previously described rTMS-induced facilitation characterized by specific prerequisites of waveform and current direction has a specific pharmacological profile suggesting PTP.
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